H. Huber

Biomay (Austria) — Austria

Medicine · Health Sciences

23h-index2.7kcitations104works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Allergic Rhinitis and Sensitization(16), Food Allergy and Anaphylaxis Research(15), Asthma and respiratory diseases(10), Molecular spectroscopy and chirality(7), Molecular Spectroscopy and Structure(6)

Publications104 total

Epicutaneous allergen application preferentially boosts specific T cell responses in sensitized patients
Scientific Reports·2017· 19 citedOpen Access
Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen–related apple allergy
Journal of Allergy and Clinical Immunology·2017· 73 cited
Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope–based grass pollen allergy vaccine with allergen extract–based vaccines
Journal of Allergy and Clinical Immunology·2017· 29 citedOpen Access
Extracorporeal IgE Immunoadsorption in Allergic Asthma: Safety and Efficacy
EBioMedicine·2017· 27 citedOpen Access
Supplementary Material for: Development of a Hypoallergenic Recombinant Parvalbumin for First-in-Man Subcutaneous Immunotherapy of Fish Allergy
Figshare·2017Open Access
Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy
EBioMedicine·2016· 136 citedOpen Access
Frequent occurrence of T cell–mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments
Journal of Allergy and Clinical Immunology·2015· 39 citedOpen Access
First clinical trial of a new IgE-adsorber in allergic asthma
2015
Development of a Hypoallergenic Recombinant Parvalbumin for First-in-Man Subcutaneous Immunotherapy of Fish Allergy
International Archives of Allergy and Immunology·2015· 105 citedOpen Access
Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy
Journal of Allergy and Clinical Immunology·2014· 139 citedOpen Access
Recombinant house dust mite allergens
Methods·2013· 51 citedOpen Access
Recombinant Mal d 1 is a reliable diagnostic tool for birch pollen allergen–associated apple allergy
Journal of Allergy and Clinical Immunology·2013· 21 cited
Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy
Journal of Allergy and Clinical Immunology·2012· 34 cited
Extracellular and intracellular anti-mutagenic effects of bile pigments in the Salmonella typhimurium reverse mutation assay
Toxicology in Vitro·2012· 14 citedOpen Access
Qualitätssicherung in der Kodierungsbegutachtung von Krankenhausfällen im G-DRG-System
Das Gesundheitswesen·2012· 2 cited
FAST: towards safe and effective subcutaneous immunotherapy of persistent life‐threatening food allergies
Clinical and Translational Allergy·2012· 67 citedOpen Access
Industrial Manufacturing of Plasmid-DNA Products for Gene Vaccination and Therapy
2011· 12 cited
Recombinant allergens: What does the future hold?
Journal of Allergy and Clinical Immunology·2011· 84 citedOpen Access
The equilibrium constant of carbon dioxide dimerization and the lifetime of the dimer
Molecular Physics·2007· 5 cited
Evaluation of pituitary microadenomas with dynamic MR imaging
European Journal of Radiology·2002· 46 cited
page 1 of 6Next →

Frequent Co-authors

Rudolf Valenta(9), Angela Neubauer(8), G. Kainz(7), Rainer Henning(6), Margarete Focke‐Tejkl(4), Milena Weber(4), Frank Stolz(4), Katharina Blatt(4), Peter Valent(4), Katarzyna Niespodziana(3), Verena Niederberger(3), Katharina Marth(3), Birgit Linhart(3), Tamar Kinaciyan(3), Stefan Wöhrl(3), Barbara Bohle(3), Franz Kasler(3), H Gaze(2), M. J. Lentze(2), Johannes Drach(2)